190 related articles for article (PubMed ID: 28637727)
1. A protocol for prospective studies of 25-hydroxyvitamin D, leptin and body mass index in relation to cutaneous melanoma incidence and survival.
Stenehjem JS; Grimsrud TK; Rees JR; Vos L; Babigumira R; Veierød MB; Robsahm TE
BMJ Open; 2017 Jun; 7(6):e014829. PubMed ID: 28637727
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D, obesity and leptin in relation to bladder cancer incidence and survival: prospective protocol study.
Gislefoss RE; Stenehjem JS; Hektoen HH; Andreassen BK; Langseth H; Axcrona K; Weiderpass E; Mondul A; Robsahm TE
BMJ Open; 2018 Mar; 8(3):e019309. PubMed ID: 29602840
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case-control study.
Berge LAM; Andreassen BK; Stenehjem JS; Larsen IK; Furu K; Juzeniene A; Roscher I; Heir T; Green A; Veierød MB; Robsahm TE
BMJ Open; 2019 Feb; 9(2):e025246. PubMed ID: 30787091
[TBL] [Abstract][Full Text] [Related]
4. Prediagnostic serum 25-hydroxyvitamin D and melanoma risk.
Stenehjem JS; Støer NC; Ghiasvand R; Grimsrud TK; Babigumira R; Rees JR; Nilsen LT; Johnsen B; Thorsby PM; Veierød MB; Robsahm TE
Sci Rep; 2020 Nov; 10(1):20129. PubMed ID: 33208828
[TBL] [Abstract][Full Text] [Related]
5. Anthropometric factors and Breslow thickness: prospective data on 2570 cases of cutaneous melanoma in the population-based Janus Cohort.
Stenehjem JS; Veierød MB; Nilsen LT; Ghiasvand R; Johnsen B; Grimsrud TK; Babigumira R; Støer NC; Rees JR; Robsahm TE
Br J Dermatol; 2018 Sep; 179(3):632-641. PubMed ID: 29858512
[TBL] [Abstract][Full Text] [Related]
6. 25-Hydroxyvitamin D in Patients With Melanoma and Factors Associated With Inadequate Levels.
Hernández-Ostiz S; Pérez-Ramada MD; Ortiz B; Requena C; Ribas G; Aznar E; Nagore E
Actas Dermosifiliogr; 2016 Nov; 107(9):758-764. PubMed ID: 27418183
[TBL] [Abstract][Full Text] [Related]
7. Prediagnostic serum 25-hydroxyvitamin D and leptin in relation to melanoma-specific death and overall death.
Stenehjem JS; Støer NC; Ghiasvand R; Grimsrud TK; Babigumira R; Rees JR; Nilsen LT; Johnsen B; Thorsby PM; Veierød MB; Robsahm TE
Pigment Cell Melanoma Res; 2022 Mar; 35(2):280-284. PubMed ID: 34978150
[No Abstract] [Full Text] [Related]
8. Anthropometric factors and cutaneous melanoma: Prospective data from the population-based Janus Cohort.
Stenehjem JS; Veierød MB; Nilsen LT; Ghiasvand R; Johnsen B; Grimsrud TK; Babigumira R; Rees JR; Robsahm TE
Int J Cancer; 2018 Feb; 142(4):681-690. PubMed ID: 28983909
[TBL] [Abstract][Full Text] [Related]
9. Melanoma risk in association with serum leptin levels and lifestyle parameters: a case-control study.
Gogas H; Trakatelli M; Dessypris N; Terzidis A; Katsambas A; Chrousos GP; Petridou ET
Ann Oncol; 2008 Feb; 19(2):384-9. PubMed ID: 17925285
[TBL] [Abstract][Full Text] [Related]
10. Plasma 25-hydroxyvitamin D and risk of non-melanoma and melanoma skin cancer: a prospective cohort study.
Afzal S; Nordestgaard BG; Bojesen SE
J Invest Dermatol; 2013 Mar; 133(3):629-636. PubMed ID: 23190899
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D and Vitamin D-binding protein and risk of bladder cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort.
Hektoen HH; Robsahm TE; Stenehjem JS; Axcrona K; Babigumira R; Mondul AM; Gislefoss RE; Andreassen BK
Cancer Med; 2021 Jun; 10(12):4107-4116. PubMed ID: 34080787
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and melanoma incidence and mortality.
Berwick M; Erdei EO
Pigment Cell Melanoma Res; 2013 Jan; 26(1):9-15. PubMed ID: 22947439
[TBL] [Abstract][Full Text] [Related]
13. Association of 25-hydroxyvitamin D levels and cutaneous melanoma: A nested case-control study of the Women's Health Initiative Observation Study.
Kwon GP; Gamba CS; Stefanick ML; Swetter SM; Li S; Shi RZ; Clarke CA; Feldman D; Millen AE; Messina C; Shikany JM; Manson JE; Chlebowski RT; Tang JY
J Am Acad Dermatol; 2018 Jul; 79(1):145-147. PubMed ID: 29908819
[No Abstract] [Full Text] [Related]
14. Elevated Serum Leptin Levels are Associated With an Increased Risk of Sentinel Lymph Node Metastasis in Cutaneous Melanoma.
Oba J; Wei W; Gershenwald JE; Johnson MM; Wyatt CM; Ellerhorst JA; Grimm EA
Medicine (Baltimore); 2016 Mar; 95(11):e3073. PubMed ID: 26986135
[TBL] [Abstract][Full Text] [Related]
15. Serum 25(OH)D and adipokines levels in people with abdominal obesity.
Karonova T; Belyaeva O; Jude EB; Tsiberkin A; Andreeva A; Grineva E; Pludowski P
J Steroid Biochem Mol Biol; 2018 Jan; 175():170-176. PubMed ID: 27629594
[TBL] [Abstract][Full Text] [Related]
16. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
17. Low serum 25-hydroxyvitamin d concentrations are associated with increased risk for melanoma and unfavourable prognosis.
Bade B; Zdebik A; Wagenpfeil S; Gräber S; Geisel J; Vogt T; Reichrath J
PLoS One; 2014; 9(12):e112863. PubMed ID: 25437008
[TBL] [Abstract][Full Text] [Related]
18. Associations of serum 25-hydroxyvitamin D level with incidence of lung cancer and histologic types in Norwegian adults: a case-cohort analysis of the HUNT study.
Sun YQ; Langhammer A; Wu C; Skorpen F; Chen Y; Nilsen TIL; Romundstad PR; Mai XM
Eur J Epidemiol; 2018 Jan; 33(1):67-77. PubMed ID: 29080012
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data.
Randerson-Moor JA; Taylor JC; Elliott F; Chang YM; Beswick S; Kukalizch K; Affleck P; Leake S; Haynes S; Karpavicius B; Marsden J; Gerry E; Bale L; Bertram C; Field H; Barth JH; Silva Idos S; Swerdlow A; Kanetsky PA; Barrett JH; Bishop DT; Bishop JA
Eur J Cancer; 2009 Dec; 45(18):3271-81. PubMed ID: 19615888
[TBL] [Abstract][Full Text] [Related]
20. Environmental Exposures Such as Smoking and Low Vitamin D Are Predictive of Poor Outcome in Cutaneous Melanoma rather than Other Deprivation Measures.
Hardie CM; Elliott F; Chan M; Rogers Z; Bishop DT; Newton-Bishop JA
J Invest Dermatol; 2020 Feb; 140(2):327-337.e2. PubMed ID: 31425707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
